Correction to: Prognostic impact of sustained new-onset atrial fibrillation in critically ill patients
- PDF / 562,196 Bytes
- 2 Pages / 595.276 x 790.866 pts Page_size
- 63 Downloads / 204 Views
CORRECTION
Correction to: Prognostic impact of sustained new‑onset atrial fibrillation in critically ill patients Takuo Yoshida1* , Shigehiko Uchino1, Yusuke Sasabuchi2, Yasuhiro Hagiwara3 and the AFTER-ICU study group © 2020 Springer-Verlag GmbH Germany, part of Springer Nature
Correction to: I ntensive Care Med (2020) 46:27–35 https://doi.org/10.1007/s00134-019-05822-8
The original version of this article unfortunately contained incorrect data for the SOFA score in the Table 1. The number of missing data of this score presented in the manuscript was also incorrect. Because the authors failed to add the score of renal part for calculating SOFA scores for each patient, the SOFA score in the primary manuscript was lower than the correct data unintentionally.
*Correspondence: [email protected] 1 Intensive Care Unit, Department of Anesthesiology, Jikei University School of Medicine, Nishi‑Shinbashi Minato‑ku, Tokyo 105‑8471, Japan Full author information is available at the end of the article The original article can be found online at https://doi.org/10.1007/s0013 4-019-05822-8.
The SOFA score was not used in the multivariable analyses and was also not discussed in the manuscript. The authors apologize for the presentation of incorrect data. The corrected Table 1 can be found below. In the results section it should read: “Data were missing only for BMI (1 patient) and SOFA score (11 patients).
Table 1 Demographic and clinical characteristics: non-sustained AF vs. sustained AF Overall (n = 412)
Non-sustained AF (n = 320)
Sustained AF (n = 92)
p value
Age, years
75 (67–81)
74 (66–80)
76 (67–83)
0.106
Male sex, n (%)
277 (67)
216 (68)
61 (66)
0.9
Body mass index, kg/m2a
22 (20–25)
22 (20–25)
23 (19–26)
0.976
Hypertension, n (%)
192 (47)
149 (47)
43 (47)
1
Diabetes, n (%)
109 (27)
88 (28)
21 (23)
0.422
Congestive heart failure, n (%)
43 (10)
36 (11)
7 (7.6)
0.438
Ischemic heart disease, n (%)
43 (10)
37 (12)
6 (6.5)
0.181
Prior stroke or TIA, n (%)
43 (10)
34 (11)
9 (9.8)
1
CHADS2 score
1 (1–2)
1 (1–2)
1 (0–2)
0.838
Chronic hemodialysis, n (%)
23 (5.6)
19 (5.9)
4 (4.3)
0.797
Previous medication Calcium-channel blockers, n (%)
135 (33)
106 (33)
29 (32)
0.802
β-Blocking agents, n (%)
56 (14)
46 (14)
10 (11)
0.49
ACE inhibitors, n (%)
22 (5.3)
19 (5.9)
3 (3.3)
0.433
ARBs, n (%)
87 (21)
64 (20)
23 (25)
0.312
Antidiabetic agents, n (%)
94 (23)
78 (24)
16 (17)
0.204
Anticoagulants, n (%)
30 (7.3)
22 (6.9)
8 (8.7)
0.504
Antiarrhythmic drugs, n (%)
5 (1.2)
5 (1.6)
0 (0)
0.591
Non-scheduled surgical, n (%)
94 (23)
71 (22)
23 (25)
Scheduled surgical, n (%)
61 (15)
48 (15)
13 (14)
Medical, n (%)
257 (62)
201 (63)
56 (61)
Patient category 0.849
APACHE II score at ICU admission
23 (18–29)
23(17–29)
24 (19–28)
SOFA at AF onsetb
7 (4–10)
7 (4–10)
8 (5–10)
0.553 0.126
From ICU admission to AF onset, days
1.6 (0.7–3.0)
1.6 (0.7–3.1)
1.7 (0.7–2.8)
0.972
Infection at AF onset, n (%)
286 (69)
Data Loading...
